(Q57955696)

13

0 references

Ruth Tal-Singer

4

object named as

Ruth Tal-Singer

0 references

Emiel F M Wouters

17

object named as

Emiel Wouters

0 references

author name string

Bartolome R. Celli

1

0 references

Nicholas Locantore

2

0 references

Julie Yates

3

0 references

Bruce E. Miller

5

0 references

Per Bakke

6

0 references

Peter Calverley

7

0 references

Harvey Coxson

8

0 references

Courtney Crim

9

0 references

Lisa D. Edwards

10

0 references

David A. Lomas

11

0 references

Annelyse Duvoix

12

0 references

Stephen Rennard

14

0 references

Edwin Silverman

15

0 references

Alvar Agustí

American Journal of Respiratory and Critical Care Medicine

18

0 references

language of work or name

English

0 references

publication date

15 May 2012

0 references

published in

0 references

volume

185

0 references

page(s)

1065-1072

0 references

issue

10

0 references

cites work

Global burden of COPD: risk factors, prevalence, and future trends

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

Validation and comparison of reference equations for the 6-min walk distance test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

Use of multiple biomarkers to improve the prediction of death from cardiovascular causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

C-reactive protein levels and survival in patients with moderate to very severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

Predictors of mortality in elderly subjects with obstructive airway disease: the PILE score

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

Characterisation of COPD heterogeneity in the ECLIPSE cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

Coming together: the ATS/ERS consensus on clinical pulmonary function testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

References values for forced spirometry. Group of the European Community Respiratory Health Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

A time-dependent discrimination index for survival data

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

Raised CRP levels mark metabolic and functional impairment in advanced COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

C-reactive protein in patients with COPD, control smokers and non-smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

Changes in forced expiratory volume in 1 second over time in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

Profiling serum biomarkers in patients with COPD: associations with clinical parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

Emerging pharmacotherapies for COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC

Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201110-1792OC